戻る
AngioDynamics Exceeds Q1 Revenue Estimates Amidst Narrower Loss
戻る
株式ニュース
テーマ
AngioDynamics Exceeds Q1 Revenue Estimates Amidst Narrower Loss
AngioDynamics Exceeds Q1 Revenue Estimates Amidst Narrower Loss
Edgen Stock
·
Oct 02 2025, 13:39
共有先
共有先
リンクをコピー
ソース：
[1] AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates
[2] AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum - Stock Titan
[3] Zacks Investment Research: Stock Research, Analysis, & Recommendations
Edgen Stock·Oct 02 2025, 13:39Edgen Stock·Oct 02 2025, 13:39
Edgen Stock·Oct 02 2025, 13:39